Abstract
OMIM: # 614105
References
Abdoli N, Sadeghian I, Mousavi K, Azarpira N, Ommati MM, Heidari R (2020) Suppression of cirrhosis-related renal injury by N-acetyl cysteine. Curr Res Pharmacol Drug Discov 1:30–38. https://doi.org/10.1016/j.crphar.2020.100006
Alijanpour Aghamaleki M, Rezapour M, Babazadeh K, Zamani H, Aghajanpour F (2019) Methylmalonate-semialdehyde dehydrogenase deficiency with cardiac presentation: a case report with literature review. J Pediatr Rev 7:55–60. https://doi.org/10.32598/jpr.7.1.55
Chambliss KL, Gray RGF, Rylance G, Pollitt RJ, Gibson KM (2000) Molecular characterization of methylmalonate semialdehyde dehydrogenase deficiency. J Inherit Metab Dis 23:497–504. https://doi.org/10.1023/A:1005616315087
Dobrowolski SF et al (2020) Clinical, biochemical, mitochondrial, and metabolomic aspects of methylmalonate semialdehyde dehydrogenase deficiency: report of a fifth case. Mol Genet Metab 129:272–277. https://doi.org/10.1016/j.ymgme.2020.01.005
Heidari R, Mousavi K, Amin S, Ommati MM, Niknahad H (2020) N-acetylcysteine treatment protects intestinal mitochondria in a surgical stress model. Trends Pharmacol Sci 6:87–96. https://doi.org/10.30476/tips.2020.85960.1042
Heidari R, Ommati MM, Niknahad H (2021) Mitochondria as biosynthetic centers and targeted therapeutics. In: Pourahmad J, Rezaei M (eds) Mitochondrial metabolism. Academic Press, pp 19–47. https://doi.org/10.1016/B978-0-12-822416-8.00008-7
Jamshidzadeh A et al (2017) Taurine treatment preserves brain and liver mitochondrial function in a rat model of fulminant hepatic failure and hyperammonemia. Biomed Pharmacother 86:514–520. https://doi.org/10.1016/j.biopha.2016.11.095
Marcadier JL et al (2013) Mutations in ALDH6A1 encoding methylmalonate semialdehyde dehydrogenase are associated with dysmyelination and transient methylmalonic aciduria. Orphanet J Rare Dis 8:98. https://doi.org/10.1186/1750-1172-8-98
Mohammadi H, Sayad A, Mohammadi M, Niknahad H, Heidari R (2020) N-acetyl cysteine treatment preserves mitochondrial indices of functionality in the brain of hyperammonemic mice. Clin Exp HEPATOL 6:106–115. https://doi.org/10.5114/ceh.2020.95814
Pollitt RJ, Green A, Smith R (1985) Excessive excretion of beta-alanine and of 3-hydroxypropionic, R- and S-3-aminoisobutyric, R- and S-3-hydroxyisobutyric and S-2-(hydroxymethyl)butyric acids probably due to a defect in the metabolism of the corresponding malonic semialdehydes. J Inherit Metab Dis 8:75–79. https://doi.org/10.1007/BF01801669
Sass JO et al (2012) 3-Hydroxyisobutyrate aciduria and mutations in the ALDH6A1 gene coding for methylmalonate semialdehyde dehydrogenase. J Inherit Metab Dis 35:437–442. https://doi.org/10.1007/s10545-011-9381-x
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this entry
Cite this entry
Heidari, R. (2023). Methylmalonate Semialdehyde Dehydrogenase Deficiency (MMSDHD). In: Rezaei, N. (eds) Genetic Syndromes. Springer, Cham. https://doi.org/10.1007/978-3-319-66816-1_1767-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-66816-1_1767-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-66816-1
Online ISBN: 978-3-319-66816-1
eBook Packages: Springer Reference MedicineReference Module Medicine